Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

Launch before the second half of 2016. What savings program will be offered?
Flat insulin allows for flexible dosing with lower likelihood of hypoglycemia. How is it priced vs. Levemir?
Smartphone user interface with no screen or buttons on the pump! Launch: 2018?
IBM and Medtronic announce the first product out of their innovative partnership.
Goal to maintain access to therapy over next six months. What challenges have been seen to date?
Will this drug be cheaper than Lantus and other insulins?
What were the risks and benefits of this drug?
New trial aims to make U500 (more concentrated) insulin easier to take.
My somewhat-impatient response to the recent New York Times article, “Some Older Patients Are Treated Not Wisely, but Too Much.”
How safe and effective is Jardiance in people with type 1 diabetes?
Plus, why this drug may also be heart healthy.
Gamechanging Xultophy (Tresiba + Victoza) also now submitted to the FDA.
New trial testing the inhaled, ultra-rapid insulin in 4-17 year olds.
When might this product reach the market?
Breaking news from Stockholm, Sweden, where our team is on the ground at the European Association for the Study of Diabetes (EASD) Conference – one of the largest...
Clinical trial currently enrolling for type 2 diabetes – find out if you qualify for this study.
Combining metformin and Jardiance into a single pill.
Approved for those who can’t tolerate more statins – is this you?
Plus, a massive $2 billion investment in new production facilities!
Why the company decided against pursuing its type 2 GLP-1 drug Victoza to the FDA for use in type 1 diabetes.

Pages